Insider buying
~$51K23K sh @ $2.24
Traded Dec 2, 2024 · filed 1 day later
The CEO of Lexaria Bioscience paid $51K out of pocket for Lexaria Bioscience shares. It was the first purchase in over a year.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 3, 2024 · Filed Dec 3, 2024
The CEO of Lexaria Bioscience paid $67K out of pocket for Lexaria Bioscience shares. Shares held went up 119% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$67,175
Shares × reported transaction price
$25K–$100K
+119.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 4.8% of the CEO's reported total pay for fiscal 2024 ($1.4M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2025-12-10. The proxy does not tag the CEO's name, so the match rests on the Form 4 title only. A size comparison, not a judgement
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −9.7% | 0.0% | −9.6% |
| 30 days | −11.6% | −2.6% | −9.0% |
| 90 days | −53.3% | −5.1% | −48.2% |
| 180 days | −62.3% | −2.5% | −59.8% |
| 365 days | −56.8% | +12.6% | −69.4% |
Past results only. Not a forecast.
Insider buying
Traded Dec 2, 2024 · filed 1 day later
The CEO of Lexaria Bioscience paid $51K out of pocket for Lexaria Bioscience shares. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.